| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-161 |
Sentence |
denotes |
Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. |
| T1 |
0-161 |
Sentence |
denotes |
Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. |
| T1 |
0-161 |
Sentence |
denotes |
Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. |
| TextSentencer_T2 |
162-399 |
Sentence |
denotes |
Structural features of heparin potentially important for heparanase-inhibitory activity were examined by measuring the ability of heparin derivatives to affect the degradation of [3H]acetylated heparan sulphate by tumor cell heparanases. |
| T2 |
162-399 |
Sentence |
denotes |
Structural features of heparin potentially important for heparanase-inhibitory activity were examined by measuring the ability of heparin derivatives to affect the degradation of [3H]acetylated heparan sulphate by tumor cell heparanases. |
| T2 |
162-399 |
Sentence |
denotes |
Structural features of heparin potentially important for heparanase-inhibitory activity were examined by measuring the ability of heparin derivatives to affect the degradation of [3H]acetylated heparan sulphate by tumor cell heparanases. |
| TextSentencer_T3 |
400-565 |
Sentence |
denotes |
IC50 values were determined using an assay which distinguished degraded from undegraded substrate by precipitation of the latter with cetylpyridinium chloride (CPC). |
| T3 |
400-565 |
Sentence |
denotes |
IC50 values were determined using an assay which distinguished degraded from undegraded substrate by precipitation of the latter with cetylpyridinium chloride (CPC). |
| T3 |
400-565 |
Sentence |
denotes |
IC50 values were determined using an assay which distinguished degraded from undegraded substrate by precipitation of the latter with cetylpyridinium chloride (CPC). |
| TextSentencer_T4 |
566-670 |
Sentence |
denotes |
Removal of heparin's 2-O-sulphate and 3-O-sulphate groups enhanced heparanase-inhibitory activity (50%). |
| T4 |
566-670 |
Sentence |
denotes |
Removal of heparin's 2-O-sulphate and 3-O-sulphate groups enhanced heparanase-inhibitory activity (50%). |
| T4 |
566-670 |
Sentence |
denotes |
Removal of heparin's 2-O-sulphate and 3-O-sulphate groups enhanced heparanase-inhibitory activity (50%). |
| TextSentencer_T5 |
671-793 |
Sentence |
denotes |
Removal of its carboxyl groups slightly lowered the activity (18%), while combining the treatments abolished the activity. |
| T5 |
671-793 |
Sentence |
denotes |
Removal of its carboxyl groups slightly lowered the activity (18%), while combining the treatments abolished the activity. |
| T5 |
671-793 |
Sentence |
denotes |
Removal of its carboxyl groups slightly lowered the activity (18%), while combining the treatments abolished the activity. |
| TextSentencer_T6 |
794-917 |
Sentence |
denotes |
At least one negative charge on the iduronic acid/idose moiety, therefore, is necessary for heparanase-inhibitory activity. |
| T6 |
794-917 |
Sentence |
denotes |
At least one negative charge on the iduronic acid/idose moiety, therefore, is necessary for heparanase-inhibitory activity. |
| T6 |
794-917 |
Sentence |
denotes |
At least one negative charge on the iduronic acid/idose moiety, therefore, is necessary for heparanase-inhibitory activity. |
| TextSentencer_T7 |
918-1004 |
Sentence |
denotes |
Replacing heparin's N-sulphate groups with N-acetyl groups reduced its activity (37%). |
| T7 |
918-1004 |
Sentence |
denotes |
Replacing heparin's N-sulphate groups with N-acetyl groups reduced its activity (37%). |
| T7 |
918-1004 |
Sentence |
denotes |
Replacing heparin's N-sulphate groups with N-acetyl groups reduced its activity (37%). |
| TextSentencer_T8 |
1005-1203 |
Sentence |
denotes |
Comparing this heparin derivative with 2,3-O-desulphated heparin, the placement of sulphate groups appears important for activity since the two structures have similar nominal linear charge density. |
| T8 |
1005-1203 |
Sentence |
denotes |
Comparing this heparin derivative with 2,3-O-desulphated heparin, the placement of sulphate groups appears important for activity since the two structures have similar nominal linear charge density. |
| T8 |
1005-1203 |
Sentence |
denotes |
Comparing this heparin derivative with 2,3-O-desulphated heparin, the placement of sulphate groups appears important for activity since the two structures have similar nominal linear charge density. |
| TextSentencer_T9 |
1204-1405 |
Sentence |
denotes |
In addition, unsubstituted uronic acids are nonessential for inhibition since their modification (periodate-oxidation/borohydride-reduction) enhanced rather than reduced heparanase-inhibitory activity. |
| T9 |
1204-1405 |
Sentence |
denotes |
In addition, unsubstituted uronic acids are nonessential for inhibition since their modification (periodate-oxidation/borohydride-reduction) enhanced rather than reduced heparanase-inhibitory activity. |
| T9 |
1204-1405 |
Sentence |
denotes |
In addition, unsubstituted uronic acids are nonessential for inhibition since their modification (periodate-oxidation/borohydride-reduction) enhanced rather than reduced heparanase-inhibitory activity. |
| TextSentencer_T10 |
1406-1675 |
Sentence |
denotes |
The most effective heparanase inhibitors (2,3-O-desulphated heparin, and [periodate-oxidized, borohydride-reduced] heparin) were tested in the chick chorioallantoic membrane (CAM) bioassay for anti-angiogenic activity and found to be at least as efficacious as heparin. |
| T10 |
1406-1675 |
Sentence |
denotes |
The most effective heparanase inhibitors (2,3-O-desulphated heparin, and [periodate-oxidized, borohydride-reduced] heparin) were tested in the chick chorioallantoic membrane (CAM) bioassay for anti-angiogenic activity and found to be at least as efficacious as heparin. |
| T10 |
1406-1675 |
Sentence |
denotes |
The most effective heparanase inhibitors (2,3-O-desulphated heparin, and [periodate-oxidized, borohydride-reduced] heparin) were tested in the chick chorioallantoic membrane (CAM) bioassay for anti-angiogenic activity and found to be at least as efficacious as heparin. |
| TextSentencer_T11 |
1676-1929 |
Sentence |
denotes |
2,3-O-desulphated heparin also significantly decreased the tumor growth of a subcutaneous human pancreatic (Ca-Pan-2) adenocarcinoma in nude mice and prolonged the survival times of C57BL/6N mice in a B16-F10 melanoma experimental lung metastasis assay. |
| T11 |
1676-1929 |
Sentence |
denotes |
2,3-O-desulphated heparin also significantly decreased the tumor growth of a subcutaneous human pancreatic (Ca-Pan-2) adenocarcinoma in nude mice and prolonged the survival times of C57BL/6N mice in a B16-F10 melanoma experimental lung metastasis assay. |
| T11 |
1676-1929 |
Sentence |
denotes |
2,3-O-desulphated heparin also significantly decreased the tumor growth of a subcutaneous human pancreatic (Ca-Pan-2) adenocarcinoma in nude mice and prolonged the survival times of C57BL/6N mice in a B16-F10 melanoma experimental lung metastasis assay. |